Patents by Inventor Sylvie Marleau

Sylvie Marleau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic peptides and uses thereof
    Patent number: 11879021
    Abstract: Novel cyclic peptide GHRP-6 analogs of formula (I): (I) or pharmaceutically acceptable esters or salts thereof, are described. These cyclic peptide GHRP-6 analogs may be used for modulating CD36 activity, for example for the treatment of CD36-related diseases, disorders or conditions in a subject, such as atherosclerosis and age-related macular degeneration.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: January 23, 2024
    Inventors: William D. Lubell, Huy Ong, Jinqiang Zhang, Dilan Mukandila Mulumba, Sylvie Marleau, Ragnhild Gaard Ohm, Ahsanullah, Samy Omri, Ramesh Chingle
  • NOVEL CYCLIC PEPTIDES AND USES THEREOF
    Publication number: 20190202863
    Abstract: Novel cyclic peptide GHRP-6 analogs of formula (I): (I) or pharmaceutically acceptable esters or salts thereof, are described. These cyclic peptide GHRP-6 analogs may be used for modulating CD36 activity, for example for the treatment of CD36-related diseases, disorders or conditions in a subject, such as atherosclerosis and age-related macular degeneration.
    Type: Application
    Filed: June 28, 2017
    Publication date: July 4, 2019
    Inventors: WILLIAM D. LUBELL, HUY ONG, JINQIANG ZHANG, DILAN MUKANDILA MULUMBA, SYLVIE MARLEAU, RAGNHILD GAARD OHM, AHSANULLAH, SAMY OMRI, RAMESH CHINGLE
  • CD36 MODULATION AND USES THEREOF
    Publication number: 20100279941
    Abstract: Methods, uses, kits and products are described for the prevention and treatment of ischemia-associated cardiopathies such as myocardial ischemia/reperfusion (I/R) injury, based on the selective modulation of CD36.
    Type: Application
    Filed: April 30, 2010
    Publication date: November 4, 2010
    Inventors: Huy Ong, Sylvie Marleau, André Carpentier, Valérie L. Bessi, Sébastien Ménard
  • Growth hormone-releasing peptides in the treatment or prevention of atherosclerosis and hypercholesterolemia
    Patent number: 7785567
    Abstract: According to the invention there is provided a method of treatment or prophylaxis of atherosclerosis, hypercholesterolemia or a cardiovascular disease associated with atherosclerosis, which method comprises administration of one or more Growth Hormone Releasing Peptides (GHRPs) to a patient in need of such treatment or prophylaxis. There are also provided methods of reducing blood plasma cholesterol levels, as well as methods of modulating the expression of the scavenger receptor CD36 and genes involved in cellular cholesterol efflux.
    Type: Grant
    Filed: August 21, 2003
    Date of Patent: August 31, 2010
    Assignees: Valorisation-Recherche, Société en Commandite, Valorisation HSJ, Société en Commandite
    Inventors: Huy Ong, Sylvie Marleau, André Tremblay
  • Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
    Publication number: 20060241054
    Abstract: According to the invention there is provided a method of treatment or prophylaxis of atherosclerosis, hypercholesterolemia or a cardiovascular disease associated with atherosclerosis, which method comprises administration of one or more Growth Hormone Releasing Peptides (GHRPs) to a patient in need of such treatment or prophylaxis. There are also provided methods of reducing blood plasma cholesterol levels, as well as methods of modulating the expression of the scavenger receptor CD36 and genes involved in cellular cholesterol efflux.
    Type: Application
    Filed: August 23, 2003
    Publication date: October 26, 2006
    Inventors: Huy Ong, Sylvie Marleau, Andre Tremblay